Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Weidhaas, J.B.
183  Ergebnisse:
Personensuche X
?
1

The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngea..:

Weidhaas, J.B. ; Harris, J. ; Gillison, M....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. S151 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Early Prediction of Radiation Treatment Response via Longit..:

Li, Z.R. ; Weidhaas, J.B. ; Raldow, A...
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. e474-e475 , 2023
Link: https://doi.org/10.1016/..
 
?
3

A Phase 2 Study of 5-Day Preoperative Radiotherapy for Pati..:

Savjani, R.R. ; Nelson, S.D. ; Dry, S.M....
International Journal of Radiation Oncology*Biology*Physics.  111 (2021)  3 - p. S41 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Prediction of Post-chemoradiotherapy Response for Patients ..:

Jia, Y. ; McKenzie, E. ; Sheng, K....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. S31-S32 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Transcriptomic Heterogeneity in Pathological Grade Group 5 ..:

Kishan, A.U. ; Romero, T. ; Grogan, T....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. E286-E287 , 2019
Link: https://doi.org/10.1016/..
 
?
6

MicroRNA-based Biomarkers predicting Long-Term Toxicity to ..:

Kishan, A.U. ; Ruan, D. ; Dang, A.T....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. S39-S40 , 2019
Link: https://doi.org/10.1016/..
 
?
7

MicroRNA-138 Regulation of PD-L1 Expression Immediately aft..:

Yuan, Y. ; Heilig, M. ; Jung, S.Y...
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. S156 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Investigating the association of rs2910164 with cancer pred..:

McVeigh, T P ; Mulligan, R J ; McVeigh, U M...
Endocrine Connections.  6 (2017)  8 - p. 614-624 , 2017
Link: https://doi.org/10.1530/..
 
?
9

cel-mir-237 and its homologue, hsa-miR-125b, modulate the c..:

Metheetrairut, C ; Adams, B D ; Nallur, S..
Oncogene.  36 (2016)  4 - p. 512-524 , 2016
Link: https://doi.org/10.1038/..
 
?
10

The KRAS-variant is a Biomarker of Cetuximab Response and A..:

Weidhaas, J.B. ; Harris, J. ; Schaue, D....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  5 - p. 941-942 , 2016
Link: https://doi.org/10.1016/..
 
?
11

Using Skin Dose Parameters Predicts Low Skin Toxicity in a ..:

Nath, S.K. ; Chen, Z. ; Rowe, B.P....
International Journal of Radiation Oncology*Biology*Physics.  87 (2013)  2 - p. S213 , 2013
Link: https://doi.org/10.1016/..
 
?
12

MicroRNA Profiling of Cutaneous T-cell Lymphoma Cell Lines:..:

Hansen, J.E. ; Reza, F. ; Nallur, S....
International Journal of Radiation Oncology*Biology*Physics.  81 (2011)  2 - p. S22 , 2011
Link: https://doi.org/10.1016/..
 
?
13

O-43 A KRAS microRNA binding site variant is a genetic mark..:

Heneghan, H.M. ; Miller, N. ; Paranjape, T....
European Journal of Cancer Supplements.  8 (2010)  6 - p. 16 , 2010
Link: https://doi.org/10.1016/..
 
?
14

Low COX-2 Expression, But Not CD34, Predicts for Worse Over..:

Doll, C.M. ; Winter, K. ; Gaffney, D.K....
International Journal of Radiation Oncology*Biology*Physics.  75 (2009)  3 - p. S150-S151 , 2009
Link: https://doi.org/10.1016/..
 
?
15

ERCC1, COX-2, and p53 Expression in Patients with Locally A..:

Doll, C.M. ; Winter, K. ; Gaffney, D.K....
International Journal of Radiation Oncology*Biology*Physics.  72 (2008)  1 - p. S355-S356 , 2008
Link: https://doi.org/10.1016/..
 
1-15